Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -99.95%-57.04K | -2,092.30%-512.19K | -4,243.70%-483.45K | 99.30%-77 | 98.92%-139 | -154.14%-28.53K | 85.39%-23.36K | 108.37%11.67K | 29.11%-10.96K | -651.29%-12.85K |
| Net income from continuing operations | -8.46%-115.22K | 13.84%-499.19K | 3.24%-178.94K | 39.90%-106.05K | 7.98%-107.98K | -5.53%-106.23K | -14.52%-579.39K | -6.02%-184.94K | -55.94%-176.44K | -3.78%-117.35K |
| Asset impairment expenditure | --0 | --0 | ---- | ---- | ---- | --0 | --20.45K | ---- | ---- | ---- |
| Remuneration paid in stock | --0 | --0 | --0 | ---- | ---- | --0 | --72.43K | --0 | ---- | ---- |
| Other non cashItems | 762.20%11.31K | 56.63%30.43K | 71.06%26.49K | -0.15%1.31K | -0.15%1.31K | 0.00%1.31K | -4.36%19.43K | -9.55%15.49K | 0.00%1.31K | 40.23%1.31K |
| Change In working capital | -38.65%46.87K | -109.79%-43.42K | -306.01%-331K | 14.09%104.66K | 3.24%106.53K | -13.32%76.39K | 36.22%443.72K | 798.04%160.67K | -4.82%91.73K | -6.55%103.19K |
| -Change in receivables | 240.23%6.95K | -29,150.00%-6.97K | -155.12%-6.91K | 132.64%1.63K | 147.32%3.26K | -691.69%-4.96K | -95.15%24 | 96.55%12.53K | 5.72%-4.98K | -801.70%-6.9K |
| -Change in prepaid assets | --0 | --0 | --0 | --0 | --0 | --0 | --67 | --0 | --0 | --67 |
| -Change in payables and accrued expense | -50.93%39.92K | -108.22%-36.45K | -318.78%-324.1K | 6.53%103.03K | -6.14%103.26K | -8.35%81.35K | 36.40%443.63K | 1,186.26%148.14K | -4.86%96.72K | -1.05%110.02K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -99.95%-57.04K | -2,092.30%-512.19K | -4,243.70%-483.45K | 99.30%-77 | 98.92%-139 | -154.14%-28.53K | 85.39%-23.36K | 108.37%11.67K | 29.11%-10.96K | -651.29%-12.85K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0.00%-3.6K | -184.32%-19.41K | -0.03%-3.6K | 0.00%-3.6K | -139.03%-8.61K | -190.59%-3.6K | 52.60%-6.83K | 0.03%-3.6K | 0.00%-3.6K | 0.00%-3.6K |
| Capital expenditure reported | 0.00%-3.6K | ---- | ---- | ---- | ---- | ---3.6K | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | -184.32%-19.41K | ---- | ---- | -139.03%-8.61K | -190.59%-3.6K | 52.60%-6.83K | ---14.4K | --7.2K | 0.00%-3.6K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 0.00%-3.6K | -184.32%-19.41K | -0.03%-3.6K | 0.00%-3.6K | -139.03%-8.61K | -190.59%-3.6K | 52.60%-6.83K | 0.03%-3.6K | 0.00%-3.6K | 0.00%-3.6K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 580K | 575K | 0 | 0 | 0 | ||||
| Net issuance payments of debt | --0 | --400K | --395K | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --0 | --180K | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --580K | --575K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 65.37%122.46K | -28.96%74.05K | -47.71%34.5K | -58.80%33.18K | -56.77%41.92K | -28.96%74.05K | 52.07%104.24K | -73.31%65.98K | 43.00%80.54K | 57.36%96.99K |
| Current changes in cash | -88.75%-60.64K | 260.35%48.41K | 990.17%87.96K | 109.09%1.32K | 46.84%-8.74K | -343.07%-32.13K | -184.58%-30.19K | 105.64%8.07K | -107.62%-14.56K | -209.74%-16.45K |
| End cash Position | 47.45%61.82K | 65.37%122.46K | 65.37%122.46K | -47.71%34.5K | -58.80%33.18K | -56.77%41.92K | -28.96%74.05K | -28.96%74.05K | -73.31%65.98K | 43.00%80.54K |
| Free cash from | -88.75%-60.64K | -2,092.30%-512.19K | -2,181.45%-467.64K | 27.01%-15.88K | 126.94%3.46K | -186.21%-32.13K | 85.39%-23.36K | 117.47%22.47K | 17.13%-21.76K | -651.29%-12.85K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.